The vitamin D receptor (VDR) mediates the pleiotropic biologic effects of 1,25 dihydroxyvitamin D 3 . Recent in vitro studies suggested that curcumin and poly-unsaturated fatty acids (PUFAs) also bind to VDR with low affinity. As potential ligands for the VDR, we hypothesized that curcumin and PUFAs would induce expression of known VDR target genes in cells. In this study, we tested whether these compounds regulated two important VDR target genes -human 
Introduction
The nuclear receptor superfamily is divided into four groups based on whether the receptor forms a homo-or heterodimer complex and what class of ligand is bound [1] . The endocrine receptors form homodimers and bind steroid hormones produced by endocrine tissues. The xenobiotic receptors function as heterodimers with retinoid-X-receptor (RXR) and bind to xenobiotic compounds, dietary lipids and cholesterol metabolites. The third group forms heterodimers with RXR and binds to thyroid hormone and vitamins A and D while the orphan receptor group lacks known ligands [1] . The vitamin D receptor (VDR, NR1I1) is widely expressed in most, if not all, human tissues and possesses characteristics of both the second and third groups [2] . It serves as the receptor for 1, 25-dihydroxyvitamin D 3 [1, 25(OH) 2 D 3 ] which binds with high affinity and for the secondary bile acid lithocholic acid (LCA) that binds with low affinity [3] . Vitamin D is obtained either from food, supplementation or synthesized in the skin by UVB irradiation of 7-dehydrocholesterol [4] . LCA is a secondary bile acid converted from primary bile acids by gut microbiota [5] . Upon engagement of a ligand, VDR forms a heterodimer with RXR and binds to vitamin D response elements (VDREs) present in about 2000 genomic locations and directly regulates approximately 200 genes [6, 7] . Target genes of the VDR contribute to bone mineral homeostasis, detoxification of exogenous and endogenous compounds, cancer prevention, mammalian hair cycling and immune function [8] .
The ability of the VDR to bind LCA suggests that it may interact with other novel ligands. To identify additional VDR ligands, Jurutka and colleagues used a mammalian two-hybrid system to test high concentrations of curcumin (CM) and the polyunsaturated fats (PUFAs) docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), arachidonic acid (AA), and linolenic acid (LA) [9] . These compounds promoted the dimerization of VDR and RXR suggesting that they may function as novel low-affinity ligands for the VDR [9] . More recently, curcumin was shown to induce expression of the VDR target genes CYP24A1, CYP3A4, TRPV6
and CDKN1A in the human colon cancer cell line Caco-2 [10] .
The human cathelicidin antimicrobial peptide (CAMP) gene encodes the hCAP18 pro-protein that is cleaved to release the active peptide LL-37. The CAMP gene is directly regulated by binding of the VDR to a VDRE located in its promoter region [11] . Expression of the human CAMP mRNA and hCAP18 is strongly induced by both 1,25(OH) 2 D 3 and LCA in keratinocytes and myeloid leukemia cell lines [11, 12] . Induction of the CAMP gene by LCA requires a 1000-fold higher concentration of LCA than 1,25(OH) 2 D 3 (1 x 10 -5 versus 1 x 10 -9 M, respectively) as it is a low-affinity ligand for the VDR . We hypothesized that if CM and PUFAs are low-affinity ligands for the VDR then at high concentrations they may induce the human CAMP gene in cells via activation of the VDR. In this study, we showed that PUFAs did not act as VDR ligands and were unable to increase expression of the CAMP gene in keratinocyte, colon and myeloid cell lines, but CM acted through a VDR-independent pathway to increase CAMP expression.
Material and methods

Compounds
Curcumin (C7727-500MG), cis-4,7,10, 
Quantitative real-time PCR (qRT-PCR)
U937, HaCaT and HT-29 cells were treated with compounds as described in the figure legends.
Total RNA was isolated using the SV Total RNA Isolation System according to the manufacturer's protocol (Promega Corporation, Madison, WI, USA). RNA (1-2 g) was converted to cDNA using SuperScript III reverse transcriptase and random hexamer primers (Invitrogen Corporation) according to the manufacturer's recommendations. PCR reactions were set up as described previously [11] . PCR was performed on a Bio-Rad iCycler iQ5 or CFX-96 QPCR system (Bio-Rad Laboratories, Hercules, CA, USA). All the threshold cycle (C t ) numbers were normalized to 18S rRNA. The probes and primers for the human CAMP, CYP24A1, FABP4 and RN18S1 genes used for qRT-PCR are described in Table 1 . were subcloned into a pXP2 firefly luciferase reporter plasmid previously [11] . A renilla luciferase reporter (phTKRL, Promega) was co-transfected to normalize firefly luciferase activities in all experiments.
Chromatin-Immunoprecipitation Assay
Chromatin-immunoprecipitation (ChIP) experiments were performed as described previously [15] . Briefly, U937 cells (10 7 Occupancy by VDR was normalized with respect to chromatin input used for immunoprecipitation. Primers and probe are listed in Table 1 .
Data analysis
All qRT-PCR and ELISA experiments were performed in triplicate or duplicate and results were represented as mean value with SD. Student's t-test was performed using Sigma Plot (Systat Software, San Jose, CA) and Microsoft Excel (Microsoft Corporation, Redmond, WA).
Results
CAMP gene expression is induced by curcumin but not PUFAs
The human CAMP and CYP24A1 are known target genes of the VDR and induced by 1,25(OH) 2 D 3 and LCA [16, 17] . We predicted that compounds that function as low-affinity ligands for the VDR would induce expression of these two genes. To test this, we treated U937
( Fig. 1 A & B) , HT-29 ( Fig. 1 C & D) and HaCaT ( Fig. 1 and LCA strongly induced expression of both the CAMP (Fig. 1 A & E) and CYP24A1 ( Fig. 1 B & F) genes in U937 and HaCaT cells. In HT-29 cells CAMP was not strongly induced by 1,25(OH) 2 D 3 or LCA, but was induced about four-fold by NaB (Fig. 1 C) . (Fig. 1 A-F) . CM consistently induced expression of human CAMP by about 3-fold (n=3, P<0.05) in U937 and HT-29 cells (Fig. 1 A & C) but not in HaCaT cells (Fig. 1 E) . In all three cell lines, CM did not induce CYP24A1 (Fig. 1 B, D & F) . To demonstrate that the PUFAs used in this study were active, we examined expression of FABP4, a gene induced by PUFAs binding the PPAR receptor in monocytes [19] . FABP4 expression was induced in U937 cells demonstrating that the compounds were functional (Fig. 2) . To ensure that induction of CAMP or CYP24A1 did not peak prior to 24 hours, we tested CM and DHA in a time course experiment (0, 3, 6, 12 and 24 hours) and observed maximal induction of CAMP by CM at 24 hours and no induction by DHA (data not shown). Collectively, these data indicate that PUFAs do not act as low-affinity agonists for the VDR and that CM induces CAMP, but not CYP24A1.
CM elevates hCAP18 levels
Treatment of U937 cells with 10 nM 1,25(OH) 2 D 3 increases levels of hCAP18 (the protein encoded by the human CAMP gene) secreted into the medium [11] . We monitored secreted levels of hCAP18 in the medium by ELISA [11] . As expected, 10 nM 1,25(OH) 2 D 3 increased secretion of hCAP18 into the medium; however, treatment with 100 µM LCA and 1 nM 1,25(OH) 2 D 3 , which induce CAMP mRNA expression to similar levels, did not enhance hCAP18 secretion and neither did CM nor the PUFAs (Fig. 3) . These results suggest that modest increases in CAMP mRNA levels may not lead to secretion of hCAP18 proteins in U937 cells.
To determine if induction of CAMP mRNA by CM would increase intracellular hCAP18 expression, U937 cells were treated with either 15 M CM, 100 M DHA, 100 M EPA, 100
M AA, 100 M LA, 100 M LCA or 10 nM 1,25(OH) 2 D 3 for 24 hours. The hCAP18 levels were measured by intracellular staining and FACS. The PUFAs did not increase hCAP18 levels (data not shown). CM increased the intracellular hCAP18 levels, however, they were lower than those induced by LCA and 1,25(OH) 2 D 3 (Fig. 4) . (Fig. 5) .
CM does not enhance 1,25(OH) 2 D 3 induction of CAMP expression
Induction of the CAMP gene by CM does not require the VDRE in the CAMP promoter.
We predicted that if CM induced CAMP through the VDR, then deletion of the VDRE in the CAMP promoter should abrogate the induction. We transfected CAMP promoter firefly luciferase reporters with or without the presence of the VDRE (pXP2-CAMP-luc and pXP2-CAMP-ΔHindIII-luc, respectively, Fig. 6 A) into U937 cells. Consistent with our previous report [11] , deletion of the VDRE in the CAMP promoter almost completely abolished induction of luciferase activity by 10 nM 1,25(OH) 2 D 3 ( Fig. 6 B) . On the other hand, CM was still capable of increasing CAMP promoter activity in the absence of the VDRE in the promoter (Fig. 6 B) . 10
M CM induced the luciferase activities by about two-fold regardless of the presence or absence of the VDRE. From these experiments, we concluded that induction of the CAMP gene by CM does require the VDRE.
CM does not increase VDR binding to the CAMP gene promoter
CM does not appear to function as a ligand for the VDR, thus we predicted that it would not increase VDR binding to the human CAMP gene promoter. To test this, we performed ChIP for VDR in U937 cells treated with CM, LCA and1,25(OH) 2 D 3 (Fig. 7) . We found that VDR binding to the CAMP promoter was increased with 1,25(OH) 2 D 3 , and LCA treatment and not by CM (Fig. 7) , strongly suggesting that CM-induced human CAMP expression occurs through a VDR-independent mechanism.
Discussion
VDR agonists are of great interest because of their potential therapeutic benefits in treating cancer, psoriasis and other diseases [20] [21] [22] [23] [24] . Thousands of analogs have been synthesized around the vitamin D backbone to reduce or eliminate its hypercalcemic side effects [25] .
Another class of VDR agonists is secondary bile acid LCA and its analogs [26] that activate VDR target genes without inducing hypercalcemia [17] . The identification of new agonists increases the toolbox of backbones upon which additional analogs can be developed.
To this end,
we tested a group of potential VDR ligands identified by a mammalian two hybrid system [9] .
We showed that CM modestly induced CAMP, but not CYP24A1 expression and that PUFAs did not induce the mRNA levels these two VDR target genes in human monocyte (U937), CM at the concentration we used can elicit ER stress [27] and a recent study showed ER stress induces human CAMP expression in keratinocytes [28] . We tested whether ER stress induced CAMP in our cell lines and were unable to demonstrate a role for this mechanism (data not shown); therefore, ER stress elicited by CM is not a likely mechanism for induction of human CAMP gene expression in our study. Collectively, these data argue that CM and PUFAs are not low affinity ligands for the VDR and CM activates CAMP expression by a currently unknown mechanism(s).
The discrepancy between our work and the previous study [9] could be attributed to several factors. First, recent molecular docking studies proposed that two ligand binding pockets exist in the VDR ligand binding domain: the genomic and alternative pockets. Vitamin D and its metabolites are ligands of the genomic pocket while CM is proposed to mainly bind to the alternative pocket [29] . Therefore, in the mammalian two hybrid system, the possible binding of FABP4 mRNA levels were measured by qRT-PCR using primers and probe as described in Table 1 . *Significant (P < 0.05) difference compared with untreated control. of CAMP expression were measured by qRT-PCR using primers and probe as described in Table   1 . 
